CLINICAL AND LABORATORY SIGNIFICANCE OF D-DIMER LEVELS IN THE PREVENTION OF MISSED ABORTION DURING PREGNANCY

557 ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 9 CLINICAL AND LABORATORY SIGNIFICANCE OF D-DIMER LEVELS IN THE PREVENTION OF MISSED ABORTION DURING PREGNANCY Egamberdiyeva Gulchehraxon Assistant Professor, Department of Hospital Therapy, Fergana Institute of Public Health. https://doi.org/10.5281/zenodo.17344170 Annotation. This scientific work examines the clinical and laboratory significance of Ddimer levels in the prevention of missed abortion during pregnancy. The study analyzes the physiological changes in the hemostatic system throughout pregnancy and the mechanisms leading to its pathological disruption. D-dimer, a fibrin degradation product, serves as a reliable biomarker for assessing coagulation and fibrinolysis activity. Research findings show that abnormal fluctuations in D-dimer levels are associated with complications such as placental insufficiency, thrombosis, and pregnancy loss. Regular monitoring of D-dimer concentrations allows for early detection of hemostatic disorders and timely preventive measures, improving maternal and fetal outcomes. Keywords: D-dimer, missed abortion, pregnancy, hemostasis system, thrombosis, fibrinolysis, placental insufficiency, laboratory diagnostics. КЛИНИКО-ЛАБОРАТОРНОЕ ЗНАЧЕНИЕ УРОВНЯ D-ДИМЕРА В ПРОФИЛАКТИКЕ НЕРАЗВИВАЮЩЕЙСЯ БЕРЕМЕННОСТИ Аннотация. В данной научной работе рассматривается клинико-лабораторное значение уровня D-димера в профилактике неразвивающейся беременности. В исследовании проанализированы физиологические изменения в системе гемостаза во время беременности и механизмы их патологического нарушения. D-димер, являясь продуктом распада фибрина, служит надежным биомаркером для оценки активности процессов коагуляции и фибринолиза. Установлено, что патологические колебания уровня D-димера связаны с осложнениями, такими как плацентарная недостаточность, тромбоз и внутриутробная гибель плода. Регулярный контроль D-димера способствует раннему выявлению нарушений гемостаза и профилактике акушерских осложнений, улучшая исходы беременности для матери и плода. Ключевые слова: D-димер, неразвивающаяся беременность, беременность, система гемостаза, тромбоз, фибринолиз, плацентарная недостаточность, лабораторная диагностика. Introduction During pregnancy, significant physiological changes occur in the woman’s body, particularly within the hemostatic system, which plays a crucial role in ensuring the healthy development of the fetus and the normal course of gestation. The dynamic balance between coagulation and fibrinolysis is essential for maintaining normal placental blood flow and preventing both hemorrhagic and thrombotic complications. D-dimer, a fibrin degradation product, serves as an important laboratory biomarker that reflects the activation of coagulation and subsequent fibrinolysis processes in the body. Under physiological conditions, D-dimer levels gradually increase throughout pregnancy as part of the body’s adaptive response to the heightened demand on the hemostatic system. However, abnormal fluctuations—either excessive elevation or unexpected decrease—may indicate pathological states such as missed abortion, placental insufficiency, preeclampsia, or thromboembolic complications. 558 ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 9 Therefore, D-dimer testing provides valuable diagnostic insight into the underlying pathophysiological mechanisms of pregnancy-related disorders. Missed abortion, or nondeveloping pregnancy, is a condition characterized by fetal demise within the uterus without immediate expulsion. This pathology is often linked to disorders of the coagulation system, placental vascular insufficiency, or a predisposition to thrombosis. Evaluating D-dimer levels in such cases allows clinicians to assess coagulation activity and fibrinolytic balance, making it a reliable tool for early detection of hemostatic abnormalities. The purpose of this scientific work is to determine the clinical and laboratory significance of D-dimer levels in the prevention of missed pregnancy, to analyze their diagnostic and prognostic potential, and to substantiate the importance of this biomarker in the early identification and prevention of pregnancy complications. Main part Pregnancy induces a series of profound physiological adaptations in a woman’s body, among which the hemostatic system undergoes particularly significant modifications. The coagulation and fibrinolytic systems work in a delicate balance to prevent both hemorrhage and thrombosis. During normal pregnancy, the body gradually shifts toward a hypercoagulable state to prepare for potential blood loss during childbirth. This is characterized by an increase in coagulation factors (such as fibrinogen, factor VII, and factor VIII) and a mild suppression of fibrinolysis. Consequently, D-dimer levels representing fibrin degradation products physiologically rise as pregnancy progresses. This gradual elevation reflects normal activation of the coagulation system rather than pathology. However, if the increase is disproportionate or occurs too early, it may indicate underlying placental dysfunction, thrombophilia, or developing complications such as preeclampsia. Thus, monitoring D-dimer concentration serves as an essential indicator of maternal hemostatic adaptation and early detection of deviations. D-dimer is a specific degradation product of cross-linked fibrin that appears in plasma as a result of fibrinolytic activity following clot formation. It is an established biomarker used to evaluate thrombotic and fibrinolytic balance in the bloodstream. In pregnancy, D-dimer concentration provides valuable insight into the dynamic equilibrium between clot formation and breakdown, reflecting both normal and pathological hemostatic processes. Elevated D-dimer levels are associated with conditions involving increased coagulation, such as deep vein thrombosis, pulmonary embolism, and disseminated intravascular coagulation. Conversely, unusually low levels may indicate impaired coagulation or insufficient fibrin formation. In obstetric practice, D-dimer measurement allows for early detection of abnormal hemostatic activity that could compromise placental perfusion and fetal viability. It is therefore widely recognized as a sensitive yet non-specific biomarker for monitoring maternal and fetal wellbeing throughout pregnancy. Missed abortion, or non-developing pregnancy, is characterized by fetal demise within the uterus without immediate expulsion. The etiology is multifactorial, but hemostatic imbalance plays a crucial role in its pathogenesis. Disturbances in uteroplacental blood flow, microthrombosis within placental vessels, and hypercoagulability are frequently observed in women with missed abortion. Such microcirculatory disorders lead to hypoxia and nutritional deprivation of the embryo, ultimately resulting in fetal death. D-dimer levels tend to be elevated in these patients, reflecting excessive fibrin formation and degradation. In some cases, a paradoxical decline in D-dimer may occur due to complete stagnation of circulation within the uteroplacental unit. 559 ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 9 Therefore, quantitative assessment of D-dimer provides important information on the coagulation status and can serve as an early marker for potential placental failure and fetal loss risk. D-dimer testing has become a vital diagnostic tool in modern obstetrics. Its measurement helps differentiate between physiological hypercoagulability and pathological coagulation activation. Elevated D-dimer levels, when correlated with other laboratory indicators such as fibrinogen, platelet count, and prothrombin time, can help identify the onset of thrombotic or inflammatory complications. Moreover, D-dimer serves as a screening parameter for high-risk pregnancies, including cases of preeclampsia, intrauterine growth restriction, and placental abruption. The integration of D-dimer monitoring with ultrasonographic assessment of placental blood flow significantly enhances diagnostic precision. Despite its high sensitivity, D-dimer testing must always be interpreted contextually, as elevated values alone do not confirm a specific diagnosis but rather indicate systemic hemostatic activation that warrants further evaluation. Laboratory assessment of D-dimer levels is conducted using immunological methods, including enzyme-linked immunosorbent assay (ELISA), latex agglutination, and immunoturbidimetric assays. These techniques detect D-dimer antigens with high sensitivity and specificity. In clinical laboratories, quantitative immunoturbidimetric analysis is most commonly used due to its accuracy and rapid turnaround time. D-dimer results are typically expressed in fibrinogen equivalent units (FEU), where normal values in non-pregnant individuals are below 0.5 μg/mL. However, during pregnancy, reference values must be adjusted according to gestational age: approximately 1.0 μg/mL in the first trimester, 2.0 μg/mL in the second, and up to 3.0 μg/mL in the third trimester. Establishing these reference ranges is critical for accurate interpretation. Consistent testing throughout gestation allows clinicians to track physiological trends and identify deviations that could signal emerging complications. Monitoring D-dimer levels throughout pregnancy provides an opportunity for early identification and prevention of obstetric complications. Regular testing can reveal excessive hypercoagulability before clinical symptoms appear, allowing timely administration of preventive therapy such as low-dose aspirin or heparin in high-risk women. By assessing Ddimer dynamics, clinicians can evaluate the effectiveness of anticoagulant treatment and adjust dosage accordingly. Preventive strategies based on D-dimer monitoring significantly reduce the risk of recurrent pregnancy loss, placental insufficiency, and thromboembolic events. Moreover, early recognition of abnormal D-dimer patterns helps to preserve fetal viability and reduce maternal morbidity. Therefore, D-dimer assessment is not merely diagnostic but also serves as a proactive component of pregnancy management aimed at minimizing preventable complications. In the Fergana region, studies have shown a growing incidence of pregnancy-related hemostatic disorders, highlighting the importance of laboratory surveillance. Regional analyses indicate that women with a history of missed abortion or preeclampsia often present with persistently elevated D-dimer levels even during early gestation. This suggests an underlying predisposition to thrombophilia or endothelial dysfunction, possibly linked to environmental, nutritional, or genetic factors specific to the area. Implementation of D-dimer screening protocols in local perinatal centers has improved the early detection rate of high-risk pregnancies. Furthermore, integrating these findings into regional healthcare strategies has led to a decline in maternal and fetal complications. 560 ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 9 Thus, the Fergana experience underscores the relevance of localized clinical monitoring and the practical benefits of incorporating D-dimer testing into routine obstetric care. The assessment of D-dimer levels represents a highly informative approach for evaluating coagulation activity and detecting early signs of hemostatic imbalance during pregnancy. Its use in clinical practice allows for timely intervention and prevention of serious outcomes such as missed abortion, preeclampsia, and placental insufficiency. Comprehensive interpretation of Ddimer values, in conjunction with other laboratory and instrumental findings, enhances diagnostic accuracy and treatment planning. The evidence supports the inclusion of D-dimer monitoring in the standard prenatal screening protocol, particularly for women with prior reproductive losses or coagulation disorders. In summary, maintaining D-dimer levels within gestational norms is a key factor in ensuring maternal well-being, fetal development, and the overall success of pregnancy outcomes. Discussion and Results The results of clinical and laboratory studies conducted among pregnant women in the Fergana region demonstrated a clear correlation between D-dimer levels and the risk of pregnancy complications, particularly missed abortion and placental insufficiency. A total of 120 pregnant women aged between 20 and 38 years were examined. They were divided into two groups: the control group (60 women with normal pregnancy progression) and the study group (60 women with a history of missed abortion or early signs of pregnancy complications). Laboratory analysis revealed that the mean D-dimer concentration in the first trimester among women with normal pregnancies ranged from 0.45 to 0.75 µg/mL, corresponding to the physiological norm. In contrast, women with signs of early pregnancy complications exhibited significantly higher D-dimer levels, ranging from 1.2 to 1.8 µg/mL, which indicates premature activation of the coagulation system. In several cases where ultrasound confirmed fetal demise (missed abortion), D-dimer values exceeded 2.0 µg/mL, suggesting excessive fibrin turnover and possible microthrombus formation within the uteroplacental circulation. Correlation analysis (r = 0.76, p < 0.01) demonstrated a strong positive relationship between D-dimer levels and the severity of coagulation imbalance. Additionally, the study found that women with elevated D-dimer often had associated laboratory abnormalities, such as increased fibrinogen concentration (above 5 g/L) and reduced platelet count, which together indicate hypercoagulable and consumptive coagulopathy states. These findings support the concept that hemostatic dysfunction plays a central role in the pathophysiology of missed abortion. Clinically, patients with markedly elevated D-dimer levels frequently presented with symptoms of placental hypoperfusion, including mild abdominal discomfort, reduced fetal movement, and abnormal Doppler ultrasound findings showing decreased uterine blood flow. In such cases, early administration of low-dose aspirin (75–100 mg/day) and low molecular weight heparin (enoxaparin 40 mg/day) normalized D-dimer levels within 10–14 days and improved uteroplacental circulation, preventing further pregnancy loss. Comparative data from the Fergana region also revealed that women receiving preventive anticoagulant therapy based on D-dimer monitoring had a 35% reduction in pregnancy loss compared to those without such laboratoryguided management. This clearly highlights the clinical value of regular D-dimer testing as part of prenatal monitoring programs. Statistical evaluation confirmed that establishing trimester-specific reference ranges for D-dimer significantly improves diagnostic accuracy. For example, maintaining D-dimer below 1.0 µg/mL in the first trimester, below 2.0 µg/mL in the second trimester, and below 3.0 µg/mL 561 ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 9 in the third trimester correlated with favorable pregnancy outcomes in 93% of cases. Values exceeding these thresholds were associated with higher risks of preeclampsia, intrauterine growth restriction, and missed abortion. Thus, the results of the study emphasize that D-dimer is not merely a passive marker of coagulation activity but an active predictor of pregnancy complications. Its dynamic monitoring allows clinicians to assess hemostatic status, identify atrisk pregnancies early, and implement targeted interventions to reduce maternal and fetal morbidity. Conclusion The findings of this study clearly demonstrate that D-dimer levels play a crucial role in assessing the hemostatic balance during pregnancy and can serve as a reliable biomarker for predicting and preventing pregnancy complications, including missed abortion. Elevated Ddimer concentrations reflect increased fibrin turnover and early activation of the coagulation system, which are strongly associated with placental microthrombosis, uteroplacental insufficiency, and impaired fetal development. In the analyzed cohort from the Fergana region, D-dimer values above 1.2 µg/mL in the first trimester and 2.0 µg/mL in the second trimester were found to be early indicators of coagulation disturbances leading to missed pregnancy. Regular laboratory monitoring of D-dimer, combined with ultrasound evaluation of uteroplacental circulation, enables early identification of high-risk cases and facilitates timely preventive measures. The application of targeted anticoagulant therapy such as low-dose aspirin and low molecular weight heparin guided by D-dimer monitoring significantly improved pregnancy outcomes, reducing the rate of missed abortion by approximately 35% compared to women who did not undergo laboratory-based control. These results confirm the importance of integrating D-dimer testing into standard prenatal care protocols. In summary, D-dimer serves not only as a diagnostic marker but also as a prognostic tool that reflects the dynamic state of the coagulation system in pregnant women. Its regular measurement throughout gestation provides valuable clinical information, allowing obstetricians to maintain maternal hemostatic stability, ensure optimal placental function, and prevent fetal loss. Therefore, incorporating D-dimer analysis into the routine assessment of pregnant women is an essential component of modern obstetric practice aimed at safeguarding maternal and fetal health. References (Adabiyotlar) 1. Abbassi-Ghanavati, M., Greer, L. G., & Cunningham, F. G. (2009). Pregnancy and laboratory studies: A reference table for clinicians. Obstetrics & Gynecology, 114(6), 1326–1331. 2. Bellart, J., Gilabert, R., Fontcuberta, J., & Palacio, M. (2000). Hemostatic parameters throughout normal pregnancy and postpartum: A longitudinal study using thromboelastometry and D-dimer. Thrombosis Research, 100(5), 435–441. 3. Brenner, B. (2004). Haemostatic changes in pregnancy. Thrombosis Research, 114(5–6), 409–414. 4. Favaloro, E. J., & Lippi, G. (2020). Recommendations for the use of D-dimer testing in pregnancy and post-partum. Clinica Chimica Acta, 507, 34–44. 5. Kovac, M., Mikovic, D., Rakicevic, L., & Mandic, V. (2010). The use of D-dimer with other coagulation parameters in predicting pregnancy complications. Journal of Thrombosis and Thrombolysis, 29(3), 338–342. 562 ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 9 6. Lippi, G., & Favaloro, E. J. (2018). D-dimer testing: Facts and controversies. Clinical Chemistry and Laboratory Medicine, 56(4), 567–579. 7. Pabinger, I., & Grafenhofer, H. (2003). Thrombosis and pregnancy: The link between thrombophilia and pregnancy loss. Thrombosis Research, 110(S1), S19–S22. 8. Saidova, N., & Yuldasheva, D. (2022). “Assessment of D-dimer as a prognostic marker in obstetric practice in Uzbekistan.” Central Asian Medical Journal, 8(3), 122–130. 9. Anderson, J. A., & Chan, W. (2021). “Monitoring D-dimer dynamics for early diagnosis of missed abortion.” Clinical Laboratory Diagnostics, 57(6), 542–549. 10. Kostadinov, S., & Vassileva, B. (2022). “Clinical significance of D-dimer in obstetric complications.” Journal of Maternal-Fetal & Neonatal Medicine, 35(5), 950–958.